Bio

Aaron Gardner advises life sciences companies on a broad spectrum of complex transactions. He helps clients navigate transactions spanning the entire product life cycle and across therapeutic areas and modalities, frequently involving the cutting-edge technologies that rapidly change the face of medicine. Before joining Latham, Mr. Gardner was a partner at another global law firm. He previously served as senior M&A counsel for a global biopharmaceutical company, which provided him with a real-world understanding of the in-house corporate legal function and substantial experience counseling corporate executives on a wide range of legal and commercial issues.